Last reviewed · How we verify

Test-Bepotastine salicylate 9.64 mg

Korea University Anam Hospital · Phase 1 active Small molecule Quality 0/100

Test-Bepotastine salicylate 9.64 mg is a Small molecule drug developed by Korea University Anam Hospital. It is currently in Phase 1 development. Also known as: Berion, Manufactured by Hanlim Pharm. Co., Ltd, Seoul, Korea.

At a glance

Generic nameTest-Bepotastine salicylate 9.64 mg
Also known asBerion, Manufactured by Hanlim Pharm. Co., Ltd, Seoul, Korea
SponsorKorea University Anam Hospital
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Test-Bepotastine salicylate 9.64 mg

What is Test-Bepotastine salicylate 9.64 mg?

Test-Bepotastine salicylate 9.64 mg is a Small molecule drug developed by Korea University Anam Hospital.

Who makes Test-Bepotastine salicylate 9.64 mg?

Test-Bepotastine salicylate 9.64 mg is developed by Korea University Anam Hospital (see full Korea University Anam Hospital pipeline at /company/korea-university-anam-hospital).

Is Test-Bepotastine salicylate 9.64 mg also known as anything else?

Test-Bepotastine salicylate 9.64 mg is also known as Berion, Manufactured by Hanlim Pharm. Co., Ltd, Seoul, Korea.

What development phase is Test-Bepotastine salicylate 9.64 mg in?

Test-Bepotastine salicylate 9.64 mg is in Phase 1.

Related